Form D · Other Health Care
352 Ingredients LLC
Sheridan, WY · CIK 0002066780
Offering snapshot reported Dec 2, 2025 · SEC filing
- Reported sold
- $1M Offering amount: $1M
- Investors reported
- 11 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Feb 8, 2025 As reported in this filing
Fundraising history
Reported soldDates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.
What changed?
Latest filing versus its linked predecessor, where available.
- Reported sold$400,000 → $1,000,000
- Reported investors4 → 11
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Dec 2, 2025 | Amendment | $1,000,000 | $600,000vs Nov 17, 2025 | 11 | SEC filing |
| Nov 17, 2025 | Initial | $400,000 | No comparison | 4 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-564209
Source: Form D, filed Dec 2, 2025. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Suresh Kumar Aravind | Director |
| Nathan Erik Fagre | Director |
| David Robert Lumley | Director, Executive |
| Murli Viswa Nathan | Director |
| Brian Edward Suddarth | Director, Executive |
| Sadasivan Vidyasagar | Director |
Issuer details
Industry: Other Health Care (See others in industry)
Address:
30 N Gould Street Ste R
Sheridan, WY, 82801
Sheridan, WY, 82801